文化大學機構典藏 CCUR:Item 987654321/26929
English  |  正體中文  |  简体中文  |  Items with full text/Total items : 46965/50831 (92%)
Visitors : 12624334      Online Users : 290
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version


    Please use this identifier to cite or link to this item: https://irlib.pccu.edu.tw/handle/987654321/26929


    Title: AN INVESTOR'S PERSPECTIVE ON INFECTIOUS DISEASES AND THEIR INFLUENCE ON MARKET BEHAVIOR
    Authors: Wang, YH (Wang, Yi-Hsien)
    Yang, FJ (Yang, Fu-Ju)
    Chen, LJ (Chen, Li-Je)
    Contributors: Dept Banking & Finance
    Keywords: biotechnology industry
    infectious diseases
    investor's perspective
    abnormal returns
    stock performance
    risk factor
    market model
    Date: 2013
    Issue Date: 2014-03-03 11:20:56 (UTC+8)
    Abstract: Recently, increasing number of infectious diseases has swept the world. The outbreak of a contagious disease not only affects the health and lives of people but also causes economic growth to stagnate. Business in the biotechnology industry is closely related to infectious diseases but what exactly is the information value of the outbreak of infectious disease on biotechnology? This study investigates how such outbreaks can affect the performance of biotechnology stocks. In the past 10 years, major statutory infectious diseases in Taiwan have included ENTEROVIRUS 71, DENGUE FEVER, SARS and H1N1. The empirical results indicate that there is a significant abnormal return on company shares in Taiwan's biotechnology industry because of statutory infectious epidemics. The relationship between the financial ratios of biotechnology companies and abnormal returns was analyzed as part of this research. The results show that the influence on R&D ratios, current ratios and assets are significant. Empirical findings reveal that the investors rationally measure operating conditions of the biotechnology companies during outbreaks of major infectious disease and adjust portfolio allocation accordingly.
    Relation: JOURNAL OF BUSINESS ECONOMICS AND MANAGEMENT Volume: 14 Special Issue: SI Supplement: 1 Pages: S112-S127
    Appears in Collections:[Department of Banking & Finance ] periodical articles

    Files in This Item:

    File Description SizeFormat
    index.html0KbHTML431View/Open


    All items in CCUR are protected by copyright, with all rights reserved.


    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback